Merck Files 2023 10-K, Details Pharmaceutical Operations
Ticker: MRK · Form: 10-K · Filed: 2024-02-26T00:00:00.000Z
Sentiment: neutral
Topics: earnings, pharmaceuticals, 10-K
TL;DR
**Merck's 2023 10-K is out, giving a full financial picture for the pharma giant.**
AI Summary
Merck & Co., Inc. filed its 10-K on February 26, 2024, for the fiscal year ended December 31, 2023. The filing details the company's financial performance and operations, with its primary business address at 2000 Galloping Hill Road, Kenilworth, NJ. The company, identified by CIK 0000310158, operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides a comprehensive overview of Merck's financial health and strategic direction, impacting investors, healthcare providers, and the pharmaceutical market.
Risk Assessment
Risk Level: medium — As a large pharmaceutical company, Merck faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Merck & Co., Inc. (company) — Filing entity
- 0000310158 (company) — Central Index Key (CIK)
- 20231231 (date) — Conformed Period of Report
- 20240226 (date) — Filed As Of Date
- 2000 Galloping Hill Road, Kenilworth, NJ (company) — Business Address
FAQ
What is the Central Index Key (CIK) for Merck & Co., Inc.?
The Central Index Key (CIK) for Merck & Co., Inc. is 0000310158.
When was Merck & Co., Inc.'s 10-K filed?
Merck & Co., Inc.'s 10-K was filed on February 26, 2024.
What is the fiscal year end for the reported period in this 10-K?
The fiscal year end for the reported period in this 10-K is December 31, 2023.
What is the business address of Merck & Co., Inc. as stated in the filing?
The business address of Merck & Co., Inc. is 2000 Galloping Hill Road, Kenilworth, NJ 07033.
What is the Standard Industrial Classification (SIC) for Merck & Co., Inc.?
Merck & Co., Inc.'s Standard Industrial Classification (SIC) is PHARMACEUTICAL PREPARATIONS [2834].
From the Filing
0001628280-24-006850.txt : 20240226 0001628280-24-006850.hdr.sgml : 20240226 20240226160655 ACCESSION NUMBER: 0001628280-24-006850 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 162 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 24678716 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 10-K 1 mrk-20231231.htm 10-K mrk-20231231 FALSE 2023 FY 0000310158 P3M http://fasb.org/us-gaap/2023#Revenues 0.1 http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#RestructuringCharges http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fas